TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
CGEM

Cullinan Oncology LLC

Healthcare · Biotechnology

15.40$ -8.5% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Income Statement

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Income Statement CGEM
Line item 2012 2013 2014 2015 2016 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – 0.00 0.00 0.44 0.43 0.00 0.00 0.00 0.00
– – – – – 0.05 0.07 0.00 0.00 0.00 0.01 0.01 0.01
– – – – – -0.05 -0.07 0.00 0.43 0.00 -0.01 -0.01 -0.01
– – – – – 11.98 16.49 0.99 1.30 1.97 3.57 2.66 3.17
– – – – – 6.25 5.39 0.39 0.66 0.86 1.02 0.98 0.92
– – – – – 18.23 21.88 1.39 1.96 -3.10 4.60 3.66 4.09
– – – – – -18.23 -21.88 -1.39 -1.53 3.10 -4.60 -3.66 -4.09
– – – – – 0.00 0.00 0.02 1.48 12.06 – – –
– – – – – -17.74 -21.27 -1.37 -1.52 3.24 -4.07 -3.11 -3.72
– – – – – 0.50 -1.59 -0.20 -0.06 0.90 -0.34 0.00 –
– – – – – -17.74 -19.68 -1.17 -1.47 2.38 -3.69 -3.11 -3.72
– – – – – -18.18 -21.81 -1.39 -1.53 -2.83 -4.58 -3.11 -3.72

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?